Foghorn Therapeutics FHTX
NASDAQ FHTX
$2.04 +0.03 (+1.49%)
At close: Oct 21, 2026 · 4:00 PM EDT

Foghorn Therapeutics (FHTX) Total Non-Current Liabilities (2020 - 2026)

Updated

Foghorn Therapeutics (FHTX) posted Total Non-Current Liabilities of $284.08 million for Q2 2026, down 6.0% from $302.14 million a year earlier and down 4.7% from the prior quarter.

Analysis

Foghorn Therapeutics (FHTX) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Foghorn Therapeutics' Total Non-Current Liabilities came in at $306.05 million, down 7.1% from FY2024.

  • Annual Total Non-Current Liabilities has declined for four consecutive years, though with a five-year compound annual growth rate of 22.8% (FY2020 to FY2025).
  • In prior years, Foghorn Therapeutics' Total Non-Current Liabilities was $329.51 million in FY2024 (-9.3%), $363.11 million in FY2023 (-10.3%), $404.74 million in FY2022 (-4.3%) and $422.76 million in FY2021 (+286.4%).
  • The Q2 2026 figure stands as the lowest quarterly Total Non-Current Liabilities since Q3 2021.
  • On a year-over-year basis, Total Non-Current Liabilities has declined in each of the last three quarters, with an average decline of 7.3% over the last four quarters.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q3 2022, with growth of 290.4%; the weakest was Q4 2023, with a decline of 10.3%.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $298.12 million (Q1 2026), $306.05 million (Q4 2025) and $293.96 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 105.50 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 106.45 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 33.91 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 35.10 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 97.04 Bn
10 Foghorn Therapeutics 142.67 Mn -183.28 Mn - 284.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 284.08 Mn
Mar 31, 2026 298.12 Mn
Dec 31, 2025 306.05 Mn
Sep 30, 2025 293.96 Mn
Jun 30, 2025 302.14 Mn
Mar 31, 2025 319.49 Mn
Dec 31, 2024 329.51 Mn
Dec 31, 2023 363.11 Mn
Sep 30, 2023 370.81 Mn
Jun 30, 2023 388.93 Mn
Mar 31, 2023 397.47 Mn
Dec 31, 2022 404.74 Mn
Sep 30, 2022 409.55 Mn
Jun 30, 2022 409.18 Mn
Mar 31, 2022 415.79 Mn
Dec 31, 2021 422.76 Mn
Sep 30, 2021 104.92 Mn
Dec 31, 2020 109.41 Mn
API Access

Foghorn Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=FHTX&period=max&api_key=YOUR_API_KEY